MedPath

An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients

Not Applicable
Completed
Conditions
Breast Cancer
Registration Number
NCT00734955
Lead Sponsor
Duke University
Brief Summary

Our objective is to develop a novel optical assay system for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens. Our group has previously shown that optical techniques can effectively discriminate between malignant and non-malignant breast tissues. We have also shown that data collection and processing from a single point on the tissue specimen requires less than 5 seconds. In addition, the technique is easily adaptable to provide sensing depths that are required for breast margin assessment. The goal of the work proposed in this protocol is to test the sensitivity and specificity of an optical assay system developed by our group, for intra operative assessment of breast tumor margins.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
485
Inclusion Criteria
  • Clinical diagnosis of Breast Cancer
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Identification of the optical signatures of breast tissue.Day of procedure

The primary outcome measure of this study is to identify the optical signatures of normal and cancerous tissue.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

Duke University Medical Center
🇺🇸Durham, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.